Fluoxetine in Refractory Superior Mesenteric Artery Syndrome by Targeting Comorbid Somatic Symptom Disorder

Clinical trial NCT07115472 · COMPLETED

Trial details

NCT number: NCT07115472
Sponsor: Xijing Hospital of Digestive Diseases
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Superior Mesenteric Artery Syndrome Somatic Symptom Disorder (DSM-5)

Start date: 2024-01-01
Primary completion: 2024-12-01
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.